Northwest Biotherapeutics | NWBO - Debt


Northwest Biotherapeutics reported $32.94M in Debt for its fiscal quarter ending in September of 2023.





Debt Change Date
Agenus USD 35.54M 2.34M Mar/2025
AstraZeneca USD 32.63B 207M Sep/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Celldex Therapeutics USD 2.62M 410K Sep/2025
Eisai JPY 236.67B 49.14B Sep/2025
Infinity Pharmaceuticals USD 0 0 Jun/2022
Merck USD 41.37B 5.97B Sep/2025
Northwest Biotherapeutics USD 32.94M 6.93M Sep/2023
Pfizer USD 60.85B 78M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025